Evaluation of the Acute Analgesic Efficacy of a Single Dose of LY3023703 in Patients With Postsurgical Dental Pain: A Parallel, Double-Blind, Randomized, Placebo and Positive Control Study
Phase of Trial: Phase II
Latest Information Update: 20 Dec 2017
Price : $35 *
At a glance
- Drugs LY 3023703 (Primary) ; Celecoxib
- Indications Dental pain; Postoperative pain
- Focus Therapeutic Use
- 31 Oct 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 31 Oct 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 10 Oct 2013 Planned end date changed from 1 Sep 2013 to 1 Nov 2013 as reported by ClinicalTrials.gov.